Introduction {#s1}
============

Fuel oxygenates are added to gasoline to boost the octane rating of lead-free gasoline and increase fuel oxygen content for cleaner combustion and reduced tailpipe emissions ([@c18]). Between 1979 and 2006, methyl tertiary-butyl ether (MTBE) was used nationwide at low levels in gasoline to replace lead as an octane rating booster or antiknocking agent ([@c18]). The Clean Air Act amendments of 1990 established a fuel oxygenate standard under which reformulated gasoline must contain at least 2% oxygen by weight ([@c23]). The oil industry responded by making substantial investments in MTBE production capacity and systems to deliver MTBE-containing gasoline to the marketplace. Until 2006, MTBE was the most widely used fuel oxygenate in the United States, followed by ethanol. Overall, MTBE was the second-most-produced chemical in the United States, with approximately 47 million barrels produced in 2005 ([@c26]). However, because of exposure and health concerns, some states banned or restricted the use of MTBE as a fuel oxygenate starting in 1999 ([@c15]). The U.S. Congress passed a law that stated the federal government would not offer liability protection for oil companies still using MTBE in fuel by May 2006, which caused MTBE to be completely phased out as a fuel oxygenate. At that time, refiners switched to using ethanol ([@c25]).

Inhalation exposure to fuel oxygenates commonly occurs during vehicle refueling or from incomplete burning of fuel. Dermal exposure occurs when gasoline is used as a hand cleanser (e.g., to remove paint) or gets on skin during refueling ([@c6]; [@c11]; [@c17]). These chemicals may potentially contaminate groundwater aquifers via leakage and spills from underground storage tanks or from precipitation of the vapor released into the atmosphere as industrial discharge or automobile exhaust ([@c1]; [@c8]; [@c28]; [@c29]). Fuel oxygenates such as MTBE are a more significant groundwater problem than many other gasoline components. Because of its water solubility, MTBE contamination from spills or leaking underwater fuel tanks can spread over a wider area than would more hydrophobic gasoline components such as benzene and toluene. When water supplies are contaminated with fuel oxygenates, human exposure can occur by direct ingestion and during showering or bathing through dermal and inhalation pathways ([@c13]; [@c22]).

Most MTBE absorbed by the body is metabolized by the liver and then eliminated in urine, primarily as 2-hydroxyisobutyrate with *tert*-butyl alcohol and 2-methyl-1,2-propanediol as minor urinary metabolites ([@c2]). Amberg et al. also investigated MTBE metabolites to estimate exposure, half-life, or susceptibility to exposure by oral administration of MTBE with three adults. Depending upon the dose, more than one-third of inhaled MTBE and *tert*-butyl alcohol may be excreted in exhaled air.

MTBE exhibits toxic and carcinogenic effects in laboratory animals. Rats exposed to MTBE through ingestion or inhalation show hepatic and reproductive toxicity, including cancers of the liver, testes, and other organs ([@c5]). After inhalation of high concentrations of MTBE ($> 3,000\text{ \ ppm}$), rats and mice show adverse central nervous system effects ([@c3]). Despite the widespread use of fuel oxygenates, epidemiological and clinical data on human health effects associated with fuel oxygenates are very limited. Acute human health effects of MTBE exposure include respiratory tract and eye irritation, nausea, headache, dizziness, and disorientation ([@c10]; [@c16]; [@c19]).

Direct measurement of MTBE in blood provides an accurate measure of internal dose, accounting for exposure from all sources and routes and providing a basis for individual exposure assessment. Despite the potential health effects of MTBE, internal dose data available from a population-representative sample have not been previously examined. This paper provides these results through an evaluation of data from the National Health and Nutrition Examination Survey (NHANES) (<https://www.cdc.gov/nchs/nhanes/index.htm>). Population-based biomonitoring data are useful to understand the prevalence and magnitude of exposure and the effect of regulatory changes ([@c21]). We assessed blood MTBE data from 2001--2012 for 16,937 NHANES participants $\geq 12\;{years}$ of age from multiple cycles of NHANES and used sample-weighted multivariate linear regression models to explore significant predictors of these levels.

Methods {#s2}
=======

Study Design {#s2.1}
------------

NHANES is a cross-sectional study designed to assess the health and nutritional status of the U.S. population by collecting questionnaire and physical examination data as well as biologic samples during 2-y sampling cycles (<https://www.cdc.gov/nchs/nhanes/index.htm>). Initially, each participant was interviewed at home, followed by a questionnaire and physical examination performed in a mobile examination center (MEC). A total of 16,937 participants 12 years of age and older had blood MTBE data measured during the 2001--2002, 2003--2004, 2005--2006, 2007--2008, 2009--2010, and 2011--2012 NHANES cycles. We also assessed 11,899 corresponding tap water samples obtained from NHANES participants' households. MTBE water data was not collected for the NHANES 2011--2012 cycle.

Analytical Methodology {#s2.2}
----------------------

We previously published the method used to quantify MTBE in human blood in the NHANES survey samples ([@c4]). Briefly, whole blood ($3\;{mL}$) was spiked with stable isotope-labeled MTBE ($$) internal standard and hermetically sealed in a $10\text{-}{mL}$ vial with a Teflon-lined silicone septum. The vial headspace was sampled via solid-phase microextraction using a Carboxen/polydimethylsiloxane fiber (Supelco) and analyzed using gas chromatography--high-resolution mass spectrometry (GC/MS). We used a 6890 Series GC (Agilent) and a MAT 95 XP magnetic sector MS (Thermo Fisher Scientific) for the measurements. We used Xcalibur software (version 1.3; Thermo Fisher Scientific) to process and quantify MTBE results. Reported results met the accuracy and precision specifications of the quality control/quality assurance program of the Centers for Disease Control and Prevention (CDC), National Center for Environmental Health, Division of Laboratory Sciences ([@c9]). Blood samples were received weekly and never frozen. Samples were analyzed within 4 wk of receipt and could be stored up to 10 wk at 4°C. Samples were analyzed continuously between 2001 and 2013.

A similar method was used to quantify MTBE in household tap water ($5\;{mL}$) ([@c7]). A GC Ultra (Thermo Finnigan) and a DSQ GC MS (Thermo Finnigan) were used. Xcalibur software (v1.3, Thermo Fisher Scientific Inc.) was used to process and quantify MTBE results.

Statistical Analysis {#s2.3}
--------------------

NHANES uses a multistage probability sample design. Respecting this complex design, we used survey sample weights to produce unbiased, nationally representative statistics and estimated their variance using Taylor series linearization, properly accounting for clustering. We used the SURVEYREG and SURVEYMEANS subroutines of SAS (version 9.4; SAS Institute Inc.) to obtain estimates, all of which are weighted with appropriate volatile organic compound (VOC) subsample weights. Sample-weighted multivariate linear regression models were fit to data from NHANES survey cycles 2001--2002 to 2011--2012, where the dependent variable was blood MTBE concentration (ng/L). The distribution of blood MTBE measurements was strongly right-skewed, which could have adversely affected hypothesis testing if analyzed without being transformed to have an approximately normal distribution. Therefore, we used the natural logarithm to transform the blood MTBE measurements for regression analysis. For blood and water, MTBE concentrations less than the limit of detection (LOD) were imputed using $\text{LOD}/\left. \sqrt{}2 \right.$. The LODs for blood and water MTBE measurements were $1.4\text{ \ ng}/L$ and $0.1\;\mu g/L$, respectively. We report slopes from these models along with their 95% confidence intervals (CIs) and *p*-values. In addition, to make interpretation easier, we report the exponentiated slopes to represent the proportional difference in biomarker concentration. Statistical significance was set to $\alpha = 0.05$.

The sample-weighted regression model included the following variables as predictors: sex, age, race/ethnicity, body mass index (BMI), poverty--income ratio (PIR), and NHANES cycle. PIR is the ratio of self-reported family income to the U.S. Census poverty threshold. Impoverishment was indicated by $\text{PIR} \leq 1$ (<https://www.cdc.gov/nchs/nhanes/index.htm>). Information for these potential confounders was self-reported. Age was categorized into the following ranges: 12--19 y, 20--39 y, 40--59 y, and $\geq 60\; y$. BMI (${kg}/m^{2}$) was measured during physical examination. Standard definitions for underweight ($\text{BMI} < 18.5$), healthy weight ($18.5 \leq \text{BMI} < 25$), and overweight/obese ($\text{BMI} \geq 25$) apply to adults $\geq 20\;{years}$ of age. Participants $< 20\;{years}$ of age were classified based on their BMI percentile for their sex and age: below the 5th percentile (underweight), between the 5th and 85th percentiles (healthy weight), and above the 85th percentile (overweight/obese) (<https://www.cdc.gov/nchs/nhanes/index.htm>). We also included the NHANES cycle as a predictor to see if there were any significant changes in blood MTBE over time.

The VOCs subsample A of the NHANES 2001--2012 cycles had 16,937 participants. Of those, 725 participants had zero or missing sampling weights and were excluded from the analysis. We removed another 3,615 participants who were missing at least one predictor used in the regression model. This left a sample size of 12,597 participants for our analysis.

People could be exposed to the MTBE used as a gasoline additive by breathing in fugitive emissions from gasoline. They also could have skin exposure to MTBE contaminate in groundwater. Assessment of three exposure situations was possible with questionnaire data available in the NHANES 2003--2004 cycle: *a*) indoor residential exposure from emissions emanating from vehicles stored in an attached garage, *b*) exposure during gasoline refueling, and *c*) exposure while showering/bathing (<https://www.cdc.gov/nchs/nhanes/index.htm>). A subset of the previous regression model was fit to only 2003--2004 data with the addition of these variables and a categorical variable for whether household water MTBE levels were above or below the LOD. An interaction between recent shower and detectable water MTBE was also included in the model because persons can inhale and have skin contact with MTBE in shower water. The 2003--2004 cycle was selected for behavioral exposure analysis because it was the first to include these exposure questions, and it preceded the complete phaseout of MTBE from gasoline in 2006.

NHANES 2003--2004 asked participants if their home had an attached garage. Participants were also asked if they had pumped gasoline into their vehicle within the last 3 d. Respondents who answered yes to this question were then asked how long since they had pumped gasoline: $< 7\; h$, 7--12 h, or $> 12\; h$. For participants responding no to the question about pumping gas in the last 3 d, the response was categorized as $> 12\; h$. The exposure intervals were selected to be relevant to the time scale of MTBE's pharmacokinetics but still provide adequate numbers of participants in each category, particularly its 2- to 4-h half-life in blood ([@c14]).

Time since last shower was categorized into 1--6 h and $> 6\; h$, based on the questions "In the last 3 d, did you take a hot shower or bath for 5 min or longer" and the number of hours since "...your last shower or hot bath." If respondents answered no to whether they had showered or bathed for 5 min or longer in the last 3 d, time since last shower was categorized as $> 6\; h$.

A sample-weighted multivariate linear regression model was fit to data from the NHANES 2003--2004 survey cycle in which the dependent variable was blood MTBE concentration (ng/L). The sample-weighted regression model included the primary model covariates (other than NHANES cycle and with age dichotomized as 20--39 or 40--59 y) plus recent gas pump exposure prior to the NHANES visit ($< 7\; h$, 7--12 h, $> 12\; h$), having an attached garage (yes, no), having showered within 6 h of the study visit (yes, no), having a detectable MTBE water level (yes, no), and an interaction between taking a hot shower within 6 h and having a detectable MTBE water level. The interaction between time of last shower and detectable water MTBE was included in the model to test whether a recent shower modified the association between blood MTBE and household water MTBE. Residential water MTBE concentrations were not included in regression models because levels of detection in water were low (16.2%) for the 2003--2004 cycle. Instead, we used a categorical variable indicating residential water MTBE concentrations above or below the detection limit. One participant was excluded because of missing questionnaire data, and 205 were excluded because of missing water concentration values.

After exclusion ($n = 206$), the sample size for NHANES 2003--2004 statistical analysis was 1,015 participants. We report slopes from the model and their 95% CIs and *p*-values. We also report the exponential slopes to represent the proportional change in biomarker concentration.

Results {#s3}
=======

Blood Methyl Tertiary-Butyl Ether Exposure: NHANES 2001--2012 {#s3.1}
-------------------------------------------------------------

Sample-weighted demographic distributions of participants eligible for statistical analysis ($n = 12,597$) indicate that most were 20--39 or 40--59 years of age (36.8% and 37.0%, respectively), 64.2% were overweight/obese, and 85.8% had incomes above the poverty level ([Table 1](#t1){ref-type="table"}). The majority (69.0%) were non-Hispanic white, followed by 11.1% non-Hispanic black, 8.5% Mexican American, and 11.4% other race/ethnicity groups (combined). Male and female participants were roughly equally represented.

###### 

Sample-weighted demographic distributions and blood methyl tertiary-butyl ether (MTBE) sample-weighted medians (ng/L) with minimum; 25th, 50th, and 75th percentiles; and maximum for National Health and Nutrition Examination Survey (NHANES) 2001--2012 participants $\geq 12\;{years}$ of age ($n = 12,597$).

Table 1 has nine columns, namely, predictor, level, N super a, demographic distribution percentage (SE), and minimum, 25th percentile, 50th percentile, 75th percentile, and maximum blood MTBE nanograms per liter concentration.

  Predictor            Level                $n$[^*a*^](#TF2){ref-type="table-fn"}   Demographic distribution \[SE (%)\]   Blood MTBE (ng/L)                                             
  -------------------- -------------------- --------------------------------------- ------------------------------------- ------------------- ---------------- ---------------- ------- -------
  All                  ---                  12,597                                  100                                   $< \text{LOD}$      $< \text{LOD}$   $< \text{LOD}$   6.05    3,800
  Sex                  Male                 6,216                                   49.5 (0.434)                          $< \text{LOD}$      $< \text{LOD}$   $< \text{LOD}$   6.40    3,800
  Female               6,381                50.5 (0.434)                            $< \text{LOD}$                        $< \text{LOD}$      $< \text{LOD}$   5.70             1,200   
  Age (y)              12--19               2,186                                   9.89 (0.384)                          $< \text{LOD}$      $< \text{LOD}$   $< \text{LOD}$   2.90    530
  20--39               4,100                36.8 (0.860)                            $< \text{LOD}$                        $< \text{LOD}$      1.41             8.31             630     
  40--59               3,575                37.0 (0.680)                            $< \text{LOD}$                        $< \text{LOD}$      1.59             9.27             1,500   
  $\geq 60$            2,736                16.3 (0.674)                            $< \text{LOD}$                        $< \text{LOD}$      $< \text{LOD}$   3.38             3,800   
  Race/ethnicity       Non-Hispanic white   5,589                                   69.0 (1.46)                           $< \text{LOD}$      $< \text{LOD}$   $< \text{LOD}$   5.97    1,500
  Non-Hispanic black   2,760                11.1 (0.822)                            $< \text{LOD}$                        $< \text{LOD}$      0.997            7.23             3,800   
  Mexican American     2,366                8.47 (0.747)                            $< \text{LOD}$                        $< \text{LOD}$      1.59             7.50             530     
  Other race           1,882                11.4 (0.747)                            $< \text{LOD}$                        $< \text{LOD}$      $< \text{LOD}$   5.04             600     
  BMI                  Underweight          219                                     1.64 (0.156)                          $< \text{LOD}$      $< \text{LOD}$   $< \text{LOD}$   6.45    880
  Healthy weight       4,287                34.1 (0.739)                            $< \text{LOD}$                        $< \text{LOD}$      $< \text{LOD}$   5.91             3,800   
  Overweight/obese     8,091                64.2 (0.744)                            $< \text{LOD}$                        $< \text{LOD}$      $< \text{LOD}$   6.12             240     
  Impoverished         No                   9,803                                   85.8 (0.584)                          $< \text{LOD}$      $< \text{LOD}$   $< \text{LOD}$   6.29    3,800
  Yes                  2,794                14.2 (0.584)                            $< \text{LOD}$                        $< \text{LOD}$      $< \text{LOD}$   4.90             240     
  NHANES cycle         2001--2002           625                                     7.78 (1.51)                           $< \text{LOD}$      6.08             25.8             68.1    286
  2003--2004           1,221                13.1 (0.787)                            $< \text{LOD}$                        2.46                9.96             46.2             680     
  2005--2006           2,905                20.0 (1.03)                             $< \text{LOD}$                        1.44                4.57             19.1             3,800   
  2007--2008           2,681                19.8 (1.07)                             $< \text{LOD}$                        $< \text{LOD}$      $< \text{LOD}$   1.42             600     
  2009--2010           2,924                19.2 (1.06)                             $< \text{LOD}$                        $< \text{LOD}$      $< \text{LOD}$   $< \text{LOD}$   448     
  2011--2012           2,241                20.2 (1.09)                             $< \text{LOD}$                        $< \text{LOD}$      $< \text{LOD}$   1.62             59.7    

Note: ---, not calculated; BMI, body mass index; LOD, limit of detection; SE, standard error.

Unweighted sample size.

Lowest detection limit in $\text{blood} = 1.4\text{ \ ng}/L$.

A total of 16,937 blood samples were assayed for MTBE during 2001--2012. The percentage of samples with blood MTBE concentrations above the detection limit decreased from 94% in 2001--2002 to 77% in 2007--2008 and to 23--28% during subsequent NHANES cycles ([Table 2](#t2){ref-type="table"}).

###### 

National Health and Nutrition Examination Survey (NHANES) 2001--2012 percentage of methyl tertiary-butyl ether (MTBE) levels above the detection limit for blood ($n = 16,937$) and water ($n = 11,899$).

Table 2 has five columns, namely, NHANES cycle, number of blood sample assayed (N), percentage of overall unweighted detect rate in blood, number of water samples assayed (N), and percentage of overall unweighted detect rate in water.

  NHANES cycle   Number of blood sample assayed (*n*)   Overall unweighted detect rate in blood (%)   Number of water samples assayed (*n*)   Overall unweighted detect rate in water (%)
  -------------- -------------------------------------- --------------------------------------------- --------------------------------------- ---------------------------------------------
  2001--2002     1,449                                  93.9                                          1,023                                   24.8
  2003--2004     1,489                                  81.6                                          1,224                                   16.2
  2005--2006     3,545                                  77.4                                          3,267                                   8.51
  2007--2008     3,415                                  27.8                                          3,177                                   1.23
  2009--2010     3,745                                  22.6                                          3,208                                   3.02
  2011--2012     3,294                                  25.4                                          ---[^*a*^](#TF5){ref-type="table-fn"}   ---[^*a*^](#TF5){ref-type="table-fn"}

Note: Limit of detection for $\text{blood} = 1.4\text{ \ ng}/L$ and $\text{water\  } = 0.1\;\mu g/L$.

Water data not measured for the 2011--2012 NHANES cycle.

We estimated that MTBE levels among women were significantly lower (by 4.9%; 95% CI: 0.4, $9.1$) than levels among men ($p = 0.035$). Participants $\geq 60\;{years}$ of age had significantly higher MTBE levels (14%; 95% CI: 3, 25) than those of the age 20- to 39-y reference group. Levels for ages 12--19 y and 40--59 y were not significantly different from the reference group ([Table 3](#t3){ref-type="table"}). Adjusted mean blood MTBE levels for NHANES cycles 2001--2002, 2003--2004, and 2005--2006 were 11.7 (95% CI: 4.31, 32.0), 8.15 (95% CI: 4.69, 14.2), and 4.53 (95% CI: 2.28, 9.00) times higher, respectively, than the mean blood MTBE level for the 2011--2012 NHANES cycle. Blood MTBE levels for the 2007--2008 and 2009--2010 NHANES cycles were not statistically different from the 2011--2012 cycle. Mean blood MTBE concentrations for each 2-y NHANES cycle decreased in parallel with decreasing 2-y mean consumption of MTBE-containing fuel in the United States ([Figure 1](#f1){ref-type="fig"} and Table S1) ([@c26]).

###### 

Sample-weighted multivariate linear regression model for blood methyl tertiary-butyl ether (MTBE) (ng/L) using National Health and Nutrition Examination Survey (NHANES) 2001--2012 data ($n = 12,597$).

Table 3 has five columns, namely, predictor, level, slope (95 percent CI), p value, and exponentiated slope (95 percent CI)\].

  Predictor                           Level                                Slope (95% CI)                    *p*-Value              Exponentiated slope (95% CI)[^*a*^](#TF7){ref-type="table-fn"}
  ----------------------------------- ------------------------------------ --------------------------------- ---------------------- ----------------------------------------------------------------
  Sex                                 Male                                 Ref                               ---                    Ref
  Female                              $- 0.0500$ ($- 0.0963$, $- 00368$)   0.035                             0.951 (0.909, 0.996)   
  Age (y)                             12--19                               0.00105 ($- 0.0925$, 0.0946)      0.98                   1.00 (0.913, 1.10)
  20--39                              Ref                                  ---                               Ref                    
  40--59                              0.0701 ($- 0.0159$, 0.156)           0.11                              1.07 (0.985, 1.17)     
  $\geq 60$                           0.127 (0.0318, 0.223)                0.0095                            1.14 (1.03, 1.25)      
  Race/ethnicity                      Non-Hispanic white                   Ref                               ---                    Ref
  Non-Hispanic black                  0.0723 ($- 0.170$, 0.314)            0.55                              1.07 (0.846, 1.37)     
  Mexican American                    0.114 ($- 0.113$, 0.340)             0.32                              1.12 (0.896, 1.40)     
  Other Hispanic or other/multirace   $- 0.00786$ ($- 0.161$, 0.146)       0.92                              0.992 (0.853, 1.15)    
  BMI                                 Underweight                          $- 0.000816$ ($- 0.227$, 0.225)   0.99                   0.999 (0.799, 1.25)
  Healthy weight                      Ref                                  ---                               Ref                    
  Overweight/obese                    0.0337 ($- 0.0360$, 0.103)           0.34                              1.03 (0.966, 1.11)     
  Impoverished                        No                                   Ref                               ---                    Ref
  Yes                                 0.0360 ($- 0.0653$, 0.137)           0.48                              1.04 (0.938, 1.15)     
  NHANES cycle                        2001--2002                           2.46 (1.45, 3.48)                 $< 0.0001$             11.7 (4.31, 32.0)
  2003--2004                          2.10 (1.54, 2.66)                    $< 0.0001$                        8.15 (4.69, 14.2)      
  2005--2006                          1.51 (0.815, 2.21)                   $< 0.0001$                        4.53 (2.28, 9.00)      
  2007--2008                          0.0298 ($- 0.139$, 0.199)            0.73                              1.03 (0.872, 1.22)     
  2009--2010                          0.00944 ($- 0.0951$, 0.114)          0.86                              1.01 (0.910, 1.12)     
  2011--2012                          Ref                                  ---                               Ref                    

Note: Unweighted sample size. The dependent variable, MTBE (ng/L), was natural log transformed for the regression model after replacing values below the limit of detection (LOD) ($1.4\text{ \ ng}/L$) with $\text{LOD}/\left. \sqrt{}2 \right.$. Adjusted $R^{2} = 0.38$. ---, not calculated; BMI, body mass index; CI, confidence interval; Ref, reference group for predictor.

For each predictor, the expected biomarker concentration in ng/L is multiplied by the exponentiated coefficient (controlling for other predictors in the model).

![Two-year mean levels of blood methyl tertiary-butyl ether (MTBE) \[least squares mean with $\pm 95\%$ confidence interval (CI) as error bars\] in the U.S. population as determined from the National Health and Nutrition Examination Survey vs. 2-y mean use of MTBE-containing fuel consumption (closed circles and line) ([@c26]). Blood data were adjusted for sex, age, race/ethnicity, body mass index, and poverty level. The dependent variable, MTBE (ng/L), was natural log transformed for the regression model after replacing values below the limit of detection (LOD) ($1.4\text{ \ ng}/L$) with $\text{LOD}/\left. \sqrt{}2 \right.$. Adjusted $R^{2} = 0.38$. See Table S1 for corresponding numeric data.](ehp-127-127003-g001){#f1}

Water Methyl Tertiary-Butyl Ether: NHANES 2001--2010 {#s3.2}
----------------------------------------------------

We also assessed 11,899 corresponding household tap water samples, which were obtained from NHANES participants' households. MTBE water data was not reported for NHANES 2011--2012 cycle. The percentage of water MTBE levels above the detection limits decreased until 2008, after which it remained at a low overall unweighted detection rate of about 1%--3% in 2009--2010. Household tap water MTBE levels were below the LOD up to the 75th percentile for all NHANES cycles, and for the last two NHANES cycles (2007--2008 and 2009--2010) ([Table 2](#t2){ref-type="table"}), MTBE levels were below the LOD up to the 95th percentile (Table S2). These data are also consistent with the decline in MTBE-containing fuel consumption over time.

The median MTBE concentration in household tap water was below the LOD for all NHANES cycles, while the concentration at the 95th percentile decreased from $0.494\;\mu g/L$ in 2001--2002 to $< \text{LOD}$ ($0.1\;\mu g/L$) in 2007--2008 and 2009--2010 (Table S2).

Water Methyl Tertiary-Butyl Ether Exposure from Gasoline and Water Use: NHANES 2003--2004 {#s3.3}
-----------------------------------------------------------------------------------------

With adjustment for other covariates, female participants in 2003--2004 had 19.0% (95% CI: 2.20, 33.0) lower blood MTBE level than males (Table S3). Model estimates based on blood MTBE data from 1,015 participants in the 2003--2004 NHANES cycle indicated that those who pumped gas $< 7\; h$ before their NHANES study visit had significantly higher MTBE levels (83%; 95% CI: 11, 201) than did those who did not pump gas within 12 h of the study visit ([Table 4](#t4){ref-type="table"}). However, the model had a relatively low $R^{2}$ value (0.051), and estimates should therefore be interpreted with caution. Detection of MTBE in household tap water was associated with higher blood MTBE levels, although the association was not significant (121% higher; 95% CI: $–5$, 412; $p = 0.09$). Blood MTBE levels were not associated with taking a hot shower within 6 h before the study visit or with having an attached garage. The interaction of taking a hot shower within 6 h before the study visit and having a detectable water MTBE concentration was not significant.

###### 

Sample-weighted demographic distributions and median blood methyl tertiary-butyl ether (MTBE) concentrations (ng/L) with 25th and 75th percentiles and regression slopes for the NHANES 2003--2004 model, ages 20--59 y ($n = 1,015$) for behavioral predictors.

Table 4 has eight columns, namely, predictor; level; N super a; demographic distribution percentage (SE); median (25th, 75th percentile) blood MTBE nanograms per liter super b; slope (95 percent CI) super c; p value; and exponentiated slope (95 percent CI).

  Predictor                                         Level                                         $n$[^*a*^](#TF9){ref-type="table-fn"}   Demographic distribution \[SE (%)\]   Median (25th, 75th percentile) blood MTBE (ng/L)[^*b*^](#TF10){ref-type="table-fn"}   Slope (95% CI)[^*c*^](#TF11){ref-type="table-fn"}   *p*-Value             Exponentiated slope (95% CI)[^*c*^](#TF11){ref-type="table-fn"}
  ------------------------------------------------- --------------------------------------------- --------------------------------------- ------------------------------------- ------------------------------------------------------------------------------------- --------------------------------------------------- --------------------- -----------------------------------------------------------------
  All                                               ---                                           1,015                                   100                                   9.93 (2.49, 46.1)                                                                     ---                                                 ---                   ---
  Gas pump exposure                                 $< 7\; h$ before                              61                                      4.79 (0.729)                          28.0 (3.90, 97.2)                                                                     Ref                                                 ---                   Ref
  7--12 h before                                    45                                            4.33 (0.760)                            16.7 (4.53, 41.1)                     0.330 ($- 0.312$, 0.972)                                                              0.29                                                1.39 (0.770, 2.51)    
  $> 12\; h$ before                                 909                                           90.9 (1.04)                             9.02 (2.40, 42.2)                     0.603 (0.0594, 1.15)                                                                  0.032                                               1.83 (1.11, 3.01)     
  Attached garage                                   No                                            691                                     63.0 (3.25)                           8.97 (2.55, 46.6)                                                                     Ref                                                 ---                   Ref
  Yes                                               324                                           37.0 (3.25)                             10.8 (2.46, 44.4)                     0.0611 ($- 0.415$, 0.537)                                                             0.79                                                1.06 (0.686, 1.65)    
  Hot shower within 6 h                             No                                            604                                     55.9 (3.25)                           9.99 (3.05, 34.0)                                                                     Ref                                                 ---                   Ref
  Yes                                               411                                           44.1 (3.25)                             8.97 (2.27, 61.0)                     $- 0.0161$ ($- 0.414$, 0.381)                                                         0.93                                                0.984 (0.683, 1.42)   
  Detectable water MTBE                             Below detectable limit                        844                                     83.9 (5.76)                           8.83 (1.66, 38.5)                                                                     Ref                                                 ---                   Ref
  Detectable result                                 171                                           16.1 (5.76)                             19.0 (5.61, 64.1)                     0.791 ($- 0.124$, 1.71)                                                               0.085                                               2.21 (0.951, 5.12)    
  Hot shower within 6 h and detectable water MTBE   No hot shower and water MTBE $< \text{LOD}$   517                                     48.9 (4.24)                           9.22 (2.28, 29.3)                                                                     Ref                                                 ---                   Ref
  No hot shower and detectable water MTBE           87                                            7.03 (2.10)                             15.6 (6.26, 59.1)                     Ref                                                                                   ---                                                 Ref                   
  Hot shower and water MTBE $< \text{LOD}$          327                                           35.1 (4.55)                             7.49 (1.38, 54.9)                     Ref                                                                                   ---                                                 Ref                   
  Hot shower and detectable water MTBE              84                                            9.02 (3.94)                             21.1 (4.94, 70.3)                     0.007 ($- 0.008$, 0.008)                                                              0.99                                                1.01 (0.486, 2.08)    

Note: ---, not calculated; CI, confidence interval; LOD, limit of detection; Ref, reference group for predictor; SE, standard error.

Unweighted sample size.

The dependent variable, MTBE (ng/L), was natural log-transformed for the regression model after replacing values below the limit of detection ($1.4\text{ \ ng}/L$) with $\text{LOD}/\left. \sqrt{}2 \right.$. Adjusted $R^{2} = 0.051$.

Slope estimates derived using adjusted multivariable linear regression model of ln-transformed blood MTBE (ng/L) adjusted for the variables shown plus gender, age (20--39 or 40--59 y), race/ethnicity (non-Hispanic white, non-Hispanic black, Mexican American, other), body mass index (BMI) (underweight, normal, overweight/obese), and poverty \[impoverished: no/yes; based on poverty--income ratio (PIR)\].

Model formula: predicted blood $\text{MTBE\ concentration} = 0.051$; blood $\text{MTBE} = \text{intercept} + \beta 1 \ast \text{Female} + \beta 2 \ast \text{Age\  }40 - 59 + \cdots + \beta 14 \ast \text{hot\  \ shower}$ within $6\text{ \ hours} \ast \text{detectable}$ water MTBE concentration, where $\beta x = \text{corresponding\  \ slope}$.

Discussion {#s4}
==========

Our analyses show that mean blood MTBE concentrations in the U.S. population decreased in parallel with the decreased consumption of MTBE-containing fuel between 2001 and 2006. In addition, participants who reported having pumped gasoline $< 7\; h$ before their study visit had significantly higher blood MTBE levels than those who had not pumped gasoline within the previous 12 h. Together, these findings together support a relationship between the use of MTBE in fuel and exposure to this chemical.

In November of 1990, amendments to the Clean Air Act were adopted; one required the use of reformulated or alternative fuels in the nation's most polluted areas ([@c23]). The fuel additive most commonly used was MTBE. In 1995, the requirement for reformulated gasoline went into effect. However, California banned the use of MTBE fuel in 2002 and New York in 2004 because of concerns about widespread exposure. Until then, these two states used 40% of the MTBE-containing fuel in the United States. Subsequently, in 2006, the United States phased out the use of gasoline reformulated with MTBE nationwide. [Figure 1](#f1){ref-type="fig"} and Table S1 show the temporal change in mean blood MTBE levels for NHANES 2001--2012 and U.S. consumption of gasoline containing MTBE ([@c24]). Nationwide consumption of MTBE-containing gasoline decreased sharply until 2007--2008 and then remained low. Blood MTBE levels decreased simultaneously with decreased use of MTBE-containing gasoline.

Exposure to MTBE through inhalation and dermal contact may occur when pumping gasoline ([@c16]). Consistent with this, our model estimates show an association between blood MTBE and pumping gas based on data from NHANES 2003--2004 that was significant for those who pumped gasoline within 7 h of their study visit, and positive though nonsignificant for those who pumped gas within 7--12 h compared with other participants. These associations are consistent with the estimated half-life of MTBE, which is approximately 2--4 h ([@c14]).

The 95th percentile levels of MTBE levels in household tap water from NHANES decreased from $0.494\text{ \ ng}/L$ to less than the detection limit between 2001 and 2008. The fraction of water samples with detectable MTBE was about 25% for 2001--2002, decreasing to about 3% for 2009--2010. We expected to see such a decrease because MTBE was removed from gasoline production nationally in 2006. MTBE can leak into groundwater (and potentially get into drinking water sources) wherever gasoline is stored, transported, or transferred. Although federal and state programs minimize the potential for leaks and spills, no system is foolproof ([@c27]).

Although detectable MTBE in residential water was associated with nominally higher blood MTBE, this association was not significant ($p = 0.085$). Brown ([@c6]) discussed the percentage of the public and people in specific occupations exposed to MTBE. He reported that 98.5% of the population is exposed to MTBE in residential water with less than the detection limit of 0.2 to $5\;\mu g/L$. Although our water MTBE detection limit was lower than the lowest discussed by Brown, our analyses were still limited by the low frequency of detectable MTBE in water samples (16.2%) and the relatively small sample size ($n = 1,015$) of the 2003--2004 model. Furthermore, the half-life of MTBE in blood is only 2--4 h ([@c14]), so variable exposure kinetics among participants who commute to the MEC could have diminished the relationship of MTBE in residential water to MTBE in blood. The detailed model did not include data from the 2001--2002 cycle because questions about pumping gas and using water were not asked before 2003. All of these factors likely contribute to the relatively poor $R^{2}\left( 0.051 \right)$ for the 2003--2004 model. Conversely, the 2001--2012 model has a better $R^{2}\left( 0.38 \right)$, likely because it effectively uses temporality as a surrogate for MTBE prevalence in the environment.

An earlier air quality study evaluated how the location of parked vehicles relative to home living areas affect indoor concentrations of MTBE in 114 residences in either Los Angeles County, California (38), Elizabeth, New Jersey (21), or Houston, Texas (55) ([@c12]). These investigators found that single-family homes with vehicles in an attached garage had a higher median difference between indoor and outdoor MTBE concentrations ($2.7{\,\mu g/m}^{3}$) compared to other situations including adjacent carports, detached garages, attached garages with no cars, and homes without both attached garages and cars. However, in our study, having a home with an attached garage was not associated with blood MTBE concentrations in participants in the NHANES 2003--2004 cycle. This might be because MTBE as an additive was rapidly being phased out of use at this time, and levels of exposure in an attached garage likely would be low. This also might be because of the relatively short half-life of MTBE ([@c14]) and the potentially long latency period between participant exposure in the home and time of blood draw. Another possibility could be that participants who responded yes to having an attached garage do not regularly park inside of it.

Conclusion {#s5}
==========

Our study revealed a decreasing trend in blood-MTBE levels in the United States from 2001--2012, suggesting a decrease in exposure to MTBE over that period. This trend coincides with the reformulation of gasoline in the United States to exclude MTBE, beginning in the 1990s, and the complete phasing out in 2006.

Supplementary Material
======================
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Click here for additional data file.
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Click here for additional data file.
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